Replies to post #360778 on Amarin Corp Plc (AMRN)

[johnchief1]

JASBG - I don't usually post too often, but I have to agree with you when you allude to manipulation. This stock price just doesn't appear to be traded in a non-manipulated market. It's amazing it is this cheap. All the cash on hand, a great product, exclusivity in the EU for years, it will take awhile to build out the EU, ties to Pfizer slowly emerging, the existence of two activist investors. There seems to be plenty of upside potential that the market just has not factored in. I have been astounded by how arrogant Judge Du has been with her poorly supported decision on obviousness. She was lacking in experience regarding patents and a bench trial, and came up with an off the wall ruling. When faced with challenges to it, she has not attempted to correct her self. She's just been stubborn. Then I was further astounded with the CAFC (Judge Dyk and his two stooges). I've never been less impressed by supposed pillars of a profession. Sure, I knew private lawyers could be super sleazy, but I never thought Federal Judges on a Court of Appeals could be so lazy and ill informed (almost seemed criminal in their actions). It seems like one of the only lawyers out there with any level of morality is Marjac. Well, I am frustrated, but at some point in time the underlying value of this company will have to surface.

[FlyFishingStocks]

J -

Fair enough - its a complex game.

Problem is where we Start (why this IS a 100% manipulated stock IMO)

It is a pretty simple game actually; stocks go up and they go down. TA/ programmed trading trumps that activity.

The vast majority of the time, stocks track the index they belong to. Rarely, will they diverge from that index.

AMRN is not 100% manipulated. It is traded like any other Biotech with negative earnings (shorted till there's no tomorrow).

It just so happens that as we approach year end, the Russel 2000 and biotech index is selling off in favor of the Nasdaq. This rotational market behavior is a big concern. The broader market is very weak, while a few tech behemoths drive the index to a new high = the markings of an unsustainable top.

This, among other reasons, is precisely why I believe risk couldn't be higher for a long position in AMRN.

There are few (if any) fundamental supporting metrics (P/E, P/S, EPS, etc.) combined with a very dismal red TA chart dominated by lower highs and a fresh break of a support trendline confirmed by volume. That combination takes 'magical hope' to overcome and turn profitable... even for the new guy at the Denner table.